Research from experts at Michigan Medicine shows that significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor. 

Early findings of two studies from the University of Michigan Rogel Cancer Center shed light on new ways to anticipate recurrence in HPV-positive head and neck cancer sooner. The papers, published in Cancer and Oral Oncology, offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow, and provide a framework for a new, more sensitive blood test that could help in this monitoring.

Children who experience cardiac arrest are one and a half times more likely to survive at a hospital capable of providing the life support system called ECMO, research suggests. But the reason behind better outcomes may have less to do with being saved by the heart and lung support machine itself and more to do with the care team structure at hospitals capable of ECM0, suggests the findings in Resuscitation.

An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.

Sugar free: investigator finds cancer cells use a new fuel in absence of sugar

Genetic testing for hereditary conditions such as breast cancer can have implications for the whole family. Learn how genetic testing helped Cathleen Argyle and her family to uncover a rare mutation and how the Rogel Cancer Center provided advice and guidance throughout the process.

By feeding T cells in the lab, researchers revealed a new metabolic pathway that could help make immunology more effective.

University of Michigan Rogel Cancer Center urological oncologist, Lindsey Herrel, MD, discusses what people should know about bladder cancer.

New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.

Focused on addressing health disparities, the Adolescent and Young Adult Oncology Program (AYA) at Michigan Medicine centers on more inclusive cancer care for this age group and dedicates its research to health equity for AYA cancer patients.

Audiologists can help with more than your hearing; they can also help with better speech and balance for children and adults.

Dr. John Krauss, medical director of the multidisciplinary colorectal cancer clinic at the Rogel Cancer Center talks about how detection for colon and rectal cancer are similar while their treatment options can be different.

Targeting this inside-the-cell checkpoint could potentially improve response to cancer immunotherapy.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.

More funding, scientific insights and clinical advances have started to drive progress in this challenging disease, and researchers see potential for immunotherapy to revolutionize its future.